Alembic Pharmaceuticals’ arm receives approval from USFDA for Glycopyrrolate tablets

04 Dec 2018 Evaluate

Alembic Pharmaceuticals’ wholly owned subsidiary, Orit Laboratories LLC has received US Food & Drug Administration (USFDA) approval for Glycopyrrolate tablets USP, 1 mg and 2 mg.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

643.00 -3.25 (-0.50%)
24-Mar-2026 11:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1765.35
Dr. Reddys Lab 1264.25
Cipla 1229.75
Zydus Lifesciences 875.20
Lupin 2315.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×